Detalles de la búsqueda
1.
The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern Italy.
Clin Immunol;
260: 109905, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38246213
2.
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know?
Rheumatology (Oxford);
63(SI): SI86-SI95, 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38320595
3.
Neuropsychiatric symptoms in Systemic Lupus Erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project.
Rheumatology (Oxford);
2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518094
4.
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Rheumatol Int;
2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609655
5.
2023 ACR/EULAR antiphospholipid syndrome classification criteria.
Ann Rheum Dis;
82(10): 1258-1270, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37640450
6.
Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study.
Rheumatology (Oxford);
2023 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37491699
7.
Attribution of neuropsychiatric symptoms and prioritisation of evidence in the diagnosis of neuropsychiatric lupus: mixed methods analysis of patient and clinician perspectives from the international INSPIRE study.
Rheumatology (Oxford);
2023 Dec 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38105443
8.
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study.
Rheumatology (Oxford);
2023 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37505460
9.
Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
Clin Exp Rheumatol;
41(3): 685-693, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377571
10.
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey.
Rheumatology (Oxford);
61(SI2): SI136-SI142, 2022 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35412604
11.
Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Lupus;
31(14): 1770-1776, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36206383
12.
Gender differences in primary antiphospholipid syndrome with vascular manifestations in 433 patients from four European centres.
Clin Exp Rheumatol;
40 Suppl 134(5): 19-26, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349408
13.
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology.
Clin Exp Rheumatol;
40(11): 2038-2043, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35260224
14.
Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism.
Neurobiol Dis;
157: 105429, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34153463
15.
Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients.
Ann Rheum Dis;
80(9): 1175-1182, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34162597
16.
EULAR recommendations for a core data set for pregnancy registries in rheumatology.
Ann Rheum Dis;
80(1): 49-56, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33055080
17.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
J Autoimmun;
124: 102729, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34600347
18.
Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study.
Rheumatology (Oxford);
60(12): 5610-5619, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33590843
19.
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Lupus;
30(14): 2276-2285, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34915764
20.
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study).
Clin Exp Rheumatol;
39(5): 938-946, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940209